Moreover, the measurement of vascular endothelial growth factor-D, a potential biomarker for diagnosis and treatment response of LAM, were not available in our institution until recently (Supplementary Table S4). The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.